Clinical Trials Directory

Trials / Completed

CompletedNCT02717273

Surgical Site Infections After Liver Transplantation Based on Perioperative Antibiotics

A Randomized, Prospective Study of Surgical Site Infections in Liver Transplant Patients Receiving Three Days of Peri-operative Antibiotic Prophylaxis Versus Intra-operative Antibiotics Only

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
102 (actual)
Sponsor
University of Virginia · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study will be to prospectively determine differences in Surgical Site Infection (SSI) if a prolonged course of post-operative antibiotics are used following liver transplantation.

Detailed description

This study will be to prospectively determine differences in SSI if a prolonged course of post-operative antibiotics are used following liver transplantation. All adult patients, admitted to the University of Virginia (UVA) Medical Center for first-time liver transplantation will be randomized to the standard of care of peri-operative antibiotics or extended course of three total days. Patients will be evaluated primarily for the presence of post-operative surgical site infections but also for fever, elevated white blood counts, secondary infections (urinary tract, pneumonia, and blood stream), length of hospital stay, graft loss, and mortality for 30 days after liver transplant.

Conditions

Interventions

TypeNameDescription
DRUGstandardperi-operative antibiotic regimen only
DRUGextendedextended three-day course of antibiotics
OTHERliver transplantorthotopic liver transplantation

Timeline

Start date
2009-03-01
Primary completion
2015-10-01
Completion
2015-10-01
First posted
2016-03-23
Last updated
2018-07-17
Results posted
2018-07-17

Source: ClinicalTrials.gov record NCT02717273. Inclusion in this directory is not an endorsement.